290 related articles for article (PubMed ID: 15670956)
1. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.
Khedkar SA; Malde AK; Coutinho EC
J Mol Graph Model; 2005 Jan; 23(4):355-66. PubMed ID: 15670956
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site.
González B; Pajares MA; Hermoso JA; Alvarez L; Garrido F; Sufrin JR; Sanz-Aparicio J
J Mol Biol; 2000 Jul; 300(2):363-75. PubMed ID: 10873471
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of S-adenosylmethionine synthetase: crystal structures of S-adenosylmethionine synthetase with ADP, BrADP, and PPi at 28 angstroms resolution.
Takusagawa F; Kamitori S; Markham GD
Biochemistry; 1996 Feb; 35(8):2586-96. PubMed ID: 8611562
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
6. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the S-adenosylmethionine synthetase ternary complex: a novel catalytic mechanism of S-adenosylmethionine synthesis from ATP and Met.
Komoto J; Yamada T; Takata Y; Markham GD; Takusagawa F
Biochemistry; 2004 Feb; 43(7):1821-31. PubMed ID: 14967023
[TBL] [Abstract][Full Text] [Related]
8. The three-dimensional structure of N-succinyldiaminopimelate aminotransferase from Mycobacterium tuberculosis.
Weyand S; Kefala G; Weiss MS
J Mol Biol; 2007 Mar; 367(3):825-38. PubMed ID: 17292400
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the acyl carrier protein synthase (AcpS) from Mycobacterium tuberculosis.
Dym O; Albeck S; Peleg Y; Schwarz A; Shakked Z; Burstein Y; Zimhony O
J Mol Biol; 2009 Nov; 393(4):937-50. PubMed ID: 19733180
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis.
Kefala G; Evans GL; Griffin MD; Devenish SR; Pearce FG; Perugini MA; Gerrard JA; Weiss MS; Dobson RC
Biochem J; 2008 Apr; 411(2):351-60. PubMed ID: 18062777
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
12. Flexible loop in the structure of S-adenosylmethionine synthetase crystallized in the tetragonal modification.
Fu Z; Hu Y; Markham GD; Takusagawa F
J Biomol Struct Dyn; 1996 Apr; 13(5):727-39. PubMed ID: 8723769
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis RmlC epimerase (Rv3465): a promising drug-target structure in the rhamnose pathway.
Kantardjieff KA; Kim CY; Naranjo C; Waldo GS; Lekin T; Segelke BW; Zemla A; Park MS; Terwilliger TC; Rupp B
Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):895-902. PubMed ID: 15103135
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
[TBL] [Abstract][Full Text] [Related]
15. The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism.
Sankaranarayanan R; Cherney MM; Cherney LT; Garen CR; Moradian F; James MN
J Mol Biol; 2008 Jan; 375(4):1052-63. PubMed ID: 18062991
[TBL] [Abstract][Full Text] [Related]
16. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation.
Ruiz F; Corrales FJ; Miqueo C; Mato JM
Hepatology; 1998 Oct; 28(4):1051-7. PubMed ID: 9755242
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
[TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
